Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €2.86 EUR
Change Today +0.011 / 0.39%
Volume 0.0
GNJC On Other Exchanges
As of 1:36 PM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

skystar bio-pharmaceutical (GNJC) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/3/14 - €5.81
52 Week Low
05/22/15 - €2.68
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

skystar bio-pharmaceutical (GNJC) Related Businessweek News

No Related Businessweek News Found

skystar bio-pharmaceutical (GNJC) Details

Skystar Bio-Pharmaceutical Company researches, develops, produces, markets, and sells veterinary healthcare and medical care products in the People’s Republic of China. The company offers micro-organism products, veterinary medicines for poultry and livestock, feed additives, and bio-pharmaceutical veterinary vaccines. It markets its products through distributers and franchise distributors, as well as directly to customers. The company is headquartered in Xi’an, the People’s Republic of China.

318 Employees
Last Reported Date: 03/31/14

skystar bio-pharmaceutical (GNJC) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $121.6K
Chief Financial Officer
Total Annual Compensation: $182.5K
Compensation as of Fiscal Year 2013.

skystar bio-pharmaceutical (GNJC) Key Developments

Skystar Bio Pharmaceutical Company announced delayed 10-Q filing

On 05/18/2015, Skystar Bio Pharmaceutical Company announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

Skystar Bio-Pharmaceutical Company Announces Receipt Of Nasdaq Non-Compliance Letter Due To Delay In Filing Form 10-K

Skystar Bio-Pharmaceutical Company announced that the Company received a notification from the Nasdaq Stock Market (Nasdaq) informing the Company that since it had not filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2014, the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1). The Nasdaq notification letter does not result in the immediate delisting of the Company’s common stock, and the stock will continue to trade uninterrupted under its current trading symbol. The Company must submit a plan of compliance with the foregoing listing deficiency by no later than June 15, 2015. If its plan is approved by the Nasdaq staff, the Company may be eligible for a listing exception of up to 180 calendar days or until October 12, 2015 to regain compliance. If the Nasdaq staff concludes that the Company will not be able to cure the deficiency, or if the Company determines not to submit the required materials or make the required representations, the Company's common stock will be subject to delisting by Nasdaq. The Company expects the completion of the 2014 audit and filing of the 2014 Annual Report by the end of May 2015, but in no event later than the Plan of Compliance Deadline.

Skystar Bio Pharmaceutical Company announced delayed annual 10-K filing

On 04/01/2015, Skystar Bio Pharmaceutical Company announced that they will be unable to file their next 10-K by the deadline required by the SEC.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GNJC:GR €2.86 EUR +0.011

GNJC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
China Animal Husbandry Industry Co Ltd CNY30.02 CNY +0.95
Guangdong VTR Bio-Tech Co Ltd CNY41.09 CNY 0.00
Inner Mongolia Jinyu Group Ltd CNY78.44 CNY +2.99
Xinjiang Tecon Animal Husbandry Bio-Technology Co Ltd CNY14.16 CNY -0.27
View Industry Companies

Industry Analysis


Industry Average

Valuation GNJC Industry Range
Price/Earnings 2.3x
Price/Sales 0.5x
Price/Book 0.2x
Price/Cash Flow 2.5x
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SKYSTAR BIO-PHARMACEUTICAL, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at